Treatment

Displaying 51 - 60 of 60

Drug delivery system for the treatment of Parkinson’s

Drug delivery system for the treatment of Parkinson’s
Renishaw’s latest drug delivery system, to be used in partnership with Herantis Pharma Plc’s drug candidate CDNF for the treatment of Parkinson’s disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union’s Framework Programme for Research and Innovation. Neurodegenerative diseases such as Parkinson’s are notoriously difficult to target with medication due to the protective role of the blood-brain barrier.
11th January 2017

Partnership could enable personalised therapies in MS

Partnership could enable personalised therapies in MS
A large global new partnership called 'MultipleMS', coordinated by Karolinska Institute in Sweden, has been awarded 15 million euro from the European Commission in the Horizon2020 program to find novel and better treatments for Multiple Sclerosis (MS). In this project, 21 universities and companies from Europe and the USA will unite efforts to tailor the development and application of therapies to the individual MS patient.
6th January 2017

Technique switches key biomolecules on and off

Technique switches key biomolecules on and off
A technique that will allow scientists to determine the effects of turning on and off a set of molecules involved in almost every cellular pathway, determine their downstream effects, and uncover new drug targets has been developed by researchers at the University of Illinois at Chicago. The finding is reported in the Proceedings of the National Academy of Sciences. Protein kinases are enzymes involved in almost every biological process.
14th December 2016


Skin cells unite to heal wounds

Skin cells unite to heal wounds
Time may not heal all wounds, but a proprietary mix of peptides and gel developed by U of T Engineering researchers heals most. A team led by Professor Milica Radisic has demonstrated for the first time that their peptide-hydrogel biomaterial prompts skin cells to "crawl" toward one another, closing chronic, non-healing wounds often associated with diabetes, such as bed sores and foot ulcers.
14th December 2016

Bringing life-saving cell therapies to the masses

Bringing life-saving cell therapies to the masses
Doctors knew long before Owen Webb was born that they were racing against the clock to save his life. Tests had confirmed the developing child suffered from Krabbe disease, a genetic disorder that causes toxins to build up in the nervous system, progressively damaging the brain. Just days after he was delivered, a medical team at Duke University began Owen on nine days of chemotherapy. His body was then infused with stem cell-rich donor umbilical cord blood.
12th December 2016

The latest weapon against Diabetes

The latest weapon against Diabetes
Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach. These pancreatic cells can do everything that natural ones do: they measure the glucose concentration in the blood and produce enough insulin to effectively lower the blood sugar level. The ETH researchers presented their development in the latest edition of the journal Science.
9th December 2016

Visual stimulation may be latest treatment for Alzheimer’s

Visual stimulation may be latest treatment for Alzheimer’s
Using LED lights flickering at a specific frequency, MIT researchers have shown that they can substantially reduce the beta amyloid plaques seen in Alzheimer’s disease, in the visual cortex of mice. This treatment appears to work by inducing brain waves known as gamma oscillations, which the researchers discovered help the brain suppress beta amyloid production and invigorate cells responsible for destroying the plaques.
8th December 2016

A radiation-free approach to imaging molecules in the brain

A radiation-free approach to imaging molecules in the brain
Scientists hoping to get a glimpse of molecules that control brain activity have devised a probe that allows them to image these molecules without using any chemical or radioactive labels. Currently the gold standard approach to imaging molecules in the brain is to tag them with radioactive probes. However, these probes offer low resolution and they can’t easily be used to watch dynamic events, says Alan Jasanoff, an MIT professor of biological engineering and brain and cognitive sciences.
5th December 2016

Light ventilator offers patients greater mobility

Light ventilator offers patients greater mobility
By reducing the weight of its life-saving ventilators, EOVE has improved the market, with the help and contribution from ASCO. EOVE designs, manufactures, and markets medical and surgical devices used during home care. Launched in 2015, the EO-150 weighs just 1.8kg, which the manufacturer claims is the lightest ventilator on the market and allows patients greater mobility.
16th November 2016

Stem cells restore vision after cataract surgery

Stem cells restore vision after cataract surgery
Researchers at University of California, San Diego School of Medicine and Shiley Eye Institute, with colleagues in China, have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses.
10th March 2016


Treatment documents

Datasheets
Whitepapers

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

LASER World of PHOTONICS 2017
26th June 2017
Germany Messe Munchen